Related Experiment Video
Updated: Aug 24, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma
Ben Davidson1, Reuven Reich, Philip Lazarovici
1Department of Pathology, The Norwegian Radium Hospital, Montebello N-0310 Oslo, University of Oslo, Oslo, Norway. bend@ulrik.uio.no
Abstract:
The objective of the present report was to study the expression of the low affinity nerve growth factor (NGF) receptor p75 and of the activated high-affinity NGF receptor TrkA in malignant mesothelioma (MM). In addition, to analyze whether expression of these receptors is site-related (pleural versus peritoneal MM, solid lesions versus effusions). Sections from 81 MM (57 biopsies, 24 effusions) were analyzed. Sixty-one mesotheliomas were of pleural origin, while the remaining 20 were peritoneal. Effusion specimens consisted of 6 peritoneal and 18 pleural effusions, while biopsies consisted of 14 peritoneal and 43 pleural lesions. Specimens were immunohistochemically stained using antibodies against p75 and phospho-TrkA (p-TrkA). Six effusions were additionally analyzed for p-TrkA expression using immunoblotting (IB). p-TrkA membrane expression (66/81 specimens; 81%) was by far more frequent than that of p75 (26/81 specimens; 32%). In addition, p-TrkA expression was significantly higher in peritoneal MM compared to their pleural counterparts (20/20 versus 46/61 positive tumors; P = 0.014). p-TrkA membrane expression was marginally higher in effusions (P = 0.058), while the opposite was true for p75 membrane expression (P = 0.008) and p-TrkA cytoplasmic expression (P = 0.003). In conclusion, our results document for the first time frequent expression of p-TrkA and lower expression of p75 in MM, in agreement with the biological aggressiveness of this tumor. The enhanced expression of p-TrkA in peritoneal MM, tumors that appear in younger patients, and in effusions as compared to solid tumors, suggest that p-TrkA plays a significant role in the biology of this disease and may aid in defining tumor progression in this setting.
Insights
Nerve growth factor (NGF) receptors p75 and TrkA were studied in malignant mesothelioma (MM). TrkA receptor expression was frequent, especially in peritoneal MM, suggesting its role in tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Malignant mesothelioma (MM) is an aggressive cancer.
- Nerve growth factor (NGF) receptors, including p75 and TrkA, are implicated in cancer cell growth and survival.
Purpose of the Study:
- To investigate the expression of p75 and activated TrkA receptors in malignant mesothelioma.
- To determine if receptor expression differs between pleural and peritoneal MM, and between solid lesions and effusions.
Main Methods:
- Immunohistochemistry was used to analyze p75 and phospho-TrkA (p-TrkA) expression in 81 MM specimens (biopsies and effusions).
- Immunoblotting was performed on six effusions to confirm p-TrkA expression.
Main Results:
- Activated TrkA (p-TrkA) membrane expression was frequent (81%), while p75 expression was less common (32%).
- p-TrkA expression was significantly higher in peritoneal MM compared to pleural MM (P = 0.014).
- p-TrkA expression was marginally higher in effusions, whereas p75 expression was higher in solid lesions.
Conclusions:
- Frequent p-TrkA and lower p75 expression in MM align with the tumor's aggressive nature.
- Enhanced p-TrkA expression in peritoneal MM and effusions suggests a significant role in disease biology and progression.
More Related Videos
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...